Savara
SVRA
#6249
Rank
A$1.41 B
Marketcap
A$6.44
Share price
-18.23%
Change (1 day)
-15.52%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -A$0.21 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.18 Billion a decrease over its 2024 earnings that were of -A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.21 Billion14.13%
2025 -A$0.18 Billion23.94%
2024 -A$0.15 Billion75.29%
2023 -A$82.64 Million43.38%
2022 -A$57.64 Million-11.31%
2021 -A$64.99 Million-13.3%
2020 -A$74.96 Million-36.53%
2019 -A$0.12 Billion13.76%
2018 -A$0.11 Billion105.54%
2017 -A$50.52 Million34.11%
2016 -A$37.67 Million-37.43%
2015 -A$60.2 Million38.81%
2014 -A$43.37 Million33.62%
2013 -A$32.46 Million38.49%
2012 -A$23.44 Million24.59%
2011 -A$18.81 Million-36.5%
2010 -A$29.62 Million-3.14%
2009 -A$30.59 Million-23.28%
2008 -A$39.86 Million8.52%
2007 -A$36.73 Million-34.14%
2006 -A$55.78 Million184.43%
2005 -A$19.61 Million90.75%
2004 -A$10.28 Million190.35%
2003 -A$3.55 Million11.64%
2002 -A$3.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.25 Billion 14.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$27.44 Million-86.97%๐Ÿ‡บ๐Ÿ‡ธ USA